Skip to main content
Clinical Trials/NCT02799004
NCT02799004
Completed
Not Applicable

Opioid Prescription for Patient With Acute Pain After Discharge From Emergency Department: Ideal Duration for Adequate Relief, Adverse Events, and Addiction

Hopital du Sacre-Coeur de Montreal1 site in 1 country761 target enrollmentJune 7, 2016
ConditionsAcute Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Pain
Sponsor
Hopital du Sacre-Coeur de Montreal
Enrollment
761
Locations
1
Primary Endpoint
Opioids consumption
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Pain is one of the most common complaints in emergency department (ED) and is still often poorly managed. A major prospective multicenter study reported that 74% of patients that had a pain complaint at ED triage are discharged in moderate to severe pain. Accordingly, physicians frequently prescribed analgesic after discharged for these patients, and opioid is given in 29% of ED visits involving pain complaints. However, few studies evaluate pain management after ED discharge: the frequency and length of opioids prescriptions, the opioids quantity taken by the patients, are the patients relieved and satisfied by these pain treatments, what are the adverse effects associated with the use of these medications, and what are the chances of developing addiction?

The primary aim of this study is to determine the required minimal opioids prescription for patients treated for acute pain after being discharge from the ED. Secondary objectives include: 1) monitor the patients' adverse events during opioids treatment; 2) evaluate the patients' level of pain relief associated with their respective opioids treatment; 3) determine the patients' level of addiction following post-ED opioids treatments.

The design of the project is a prospective observational cohort study. A cohort of consecutive ED patients aged 18 or more with an initial pain at triage of 4 or more and discharged from the ED in less than 48 hours with a prescription of opioid will be asked to participate in the study. Patients will be excluded if there is ongoing treatment for a pre-existing chronic pain condition or if they used opioid drugs in the past year. Research nurses will contact the patients by phone at three follow-up time points (1 week, 1 month, and 3 months). Follow-up phone interviews will evaluate pain intensity as well as pain treatment satisfaction (0-10 NRS), monitor adverse events, and investigate possible opioids addiction (SOWS: subjective opioid withdrawal scale). During these interviews, the nurses will also question the patients about their daily opioids usage and if they were relieved from pain.

This study will provide the base for future guidelines regarding the prescription of opioids treatment for specific pathology encountered in ED. It will also give indications on how to adjust the treatments according to adverse events and the level of addiction experienced by patients.

Registry
clinicaltrials.gov
Start Date
June 7, 2016
End Date
September 30, 2018
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Raoul Daoust

Researcher and Associate Professor

Hopital du Sacre-Coeur de Montreal

Eligibility Criteria

Inclusion Criteria

  • 18 years and older
  • Pain level at 4 or greater at triage
  • Acute pain (2 weeks or less)
  • Opioids prescription at discharge

Exclusion Criteria

  • Language barrier
  • Pregnancy
  • Treated for chronic pain
  • Hospital stay greater than 48 hours

Outcomes

Primary Outcomes

Opioids consumption

Time Frame: 2 weeks

The number of opioids taken after ED discharge for a given pathology

Secondary Outcomes

  • Pain relief(2 weeks)
  • Addiction(3 months)
  • Side effects(2 weeks)

Study Sites (1)

Loading locations...

Similar Trials